NSE:MAXHEALTH
Max Healthcare Institute Ltd · NSE · Healthcare · INR · FY for 2026
Figures on this page computed 2026-11-06 23:48 UTC
Last close
n/aINR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
62.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
11.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
17.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
1.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.32Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.2%Dividend yield
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Price is the furthest below its sector's middle: 0.10 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales2.21x
Its own average over 10 years, 37.91B.
- Profit2.22x
Its own average over 8 years, 6.50B.
- Free cash flow0.67x
Its own average over 10 years, 2.23B.
- Debt2.24x
Its own average over 10 years, 15.54B.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 2.24 times.
The filed years, as a table
10Each line is 100 at 2017-03-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2017-03-31 | 100.0 | 100.0 |
| 2018-03-31 | 107.6 | 100.0 |
| 2019-03-31 | 105.3 | 100.0 |
| 2020-03-31 | 65.8 | 98.4 |
| 2021-03-31 | 155.9 | 158.2 |
| 2022-03-31 | 244.7 | 177.6 |
| 2023-03-31 | 283.7 | 178.1 |
| 2024-03-31 | 336.1 | 178.7 |
| 2025-03-31 | 437.0 | 179.1 |
| 2026-03-31 | 520.6 | 179.2 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Figures behind the shape
Growth
27.3%faster is higher, placed against 4,940 companies as of 2026-11-05
Five-year revenue growth rate27.3%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
One-year change in net income34.1%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Returns on capital
11.4%higher is higher, placed against 5,079 companies as of 2026-11-05
Return on invested capital11.4%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity13.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets8.4%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
78.6%wider is higher, placed against 3,410 companies as of 2026-11-05
Gross margin78.6%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin21.4%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin17.2%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin1.8%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
62.8xcheaper is higher, placed against 4,359 companies as of 2026-11-05
Price to earnings62.8x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
Price to book8.5x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA39.9x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio10.9x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
0.32safer is higher, placed against 3,226 companies as of 2026-11-05
Debt to equity0.32
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio0.89
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage7.6x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Score9.60
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
0.2%more, and better covered, is higher, placed against 1,089 companies as of 2026-11-05
Dividend yield0.2%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Payout ratio10.1%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio1.0x
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- INR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.